Condition
EEG Power Spectra
Total Trials
4
Recruiting
0
Active
1
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Not Yet Recruiting2
Active Not Recruiting1
Unknown1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07533370Not ApplicableNot Yet Recruiting
Extended Emergence Strategy on Post-Anesthesia Care Unit Events After Outpatient Orthopedic Surgery
NCT06922734Active Not Recruiting
Epilepsy Watch After Vascular Events: Frequency, Outcomes, and Risk Markers
NCT07254975Not Yet Recruiting
An Observational Prospective Study of Anesthetic Sensitivity Assessed by Alpha Band Power and Its Association With Emergence Time From Sevoflurane General Anesthesia in Young Adults.
NCT03515876Unknown
Dexmedetomidine on Segmental EEG Power Spectra
Showing all 4 trials